Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2017-004601-40Phase 3Completed
Phase 3, open-label, single-arm trial of methoxyflurane in acute pain, sponsored by Mundipharma Research. Primary endpoint: Change in pain intensity at 10 minutes. Started May 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2017-004601-40.